Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
carboprost tromethamine prostaglandin e2 receptor ep1 subtype small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Fetal Membranes
Premature Rupture[MeSHID:D005322]
Disease[MeSHID:D004194]
Postpartum Hemorrhage[MeSHID:D006473]
Pregnancy[MeSHID:D011247]
Uterine Inertia[MeSHID:D014593]
Fetal Tissue[MeSHID:D005333]
Uterus[MeSHID:D014599]
Menstruation[MeSHID:D008598]
Tissue membrane[MeSHID:D008566]
Rupture
Spontaneous[MeSHID:D012422]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved agonist
carboprost tromethamine prostaglandin f2-alpha receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Fetal Membranes
Premature Rupture[MeSHID:D005322]
Disease[MeSHID:D004194]
Postpartum Hemorrhage[MeSHID:D006473]
Pregnancy[MeSHID:D011247]
Uterine Inertia[MeSHID:D014593]
Fetal Tissue[MeSHID:D005333]
Uterus[MeSHID:D014599]
Menstruation[MeSHID:D008598]
Tissue membrane[MeSHID:D008566]
Rupture
Spontaneous[MeSHID:D012422]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 3.74 approved agonist
carboprost tromethamine prostaglandin f2-alpha receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Fetal Membranes
Premature Rupture[MeSHID:D005322]
Disease[MeSHID:D004194]
Postpartum Hemorrhage[MeSHID:D006473]
Pregnancy[MeSHID:D011247]
Uterine Inertia[MeSHID:D014593]
Fetal Tissue[MeSHID:D005333]
Uterus[MeSHID:D014599]
Menstruation[MeSHID:D008598]
Tissue membrane[MeSHID:D008566]
Rupture
Spontaneous[MeSHID:D012422]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved unknown
click here to return to the previous page